Digitisation | April 05, 2023
Dozee Raises $6 million to bolster its ambition of ‘HarBedDozeeBed’
Dozee plans to further tap over 2,000 hospitals in more than 100 districts
Dozee plans to further tap over 2,000 hospitals in more than 100 districts
First approved therapeutic regimen that combines an anti-PD-1 and an antibody-drug conjugate in the US in these patients
SCYNEXIS will receive an upfront payment of $90 million with future performance-based milestone payments and tiered royalties
NDA supported by data from global Phase III FRESCO-2 study in the U.S., Europe, Japan and Australia along with data from Phase III FRESCO study conducted in China
Launch of the Da Vinci Xi Robotic System is the highlight of the Robotic Colorectal Cancer Symposium organized with the Association of Colon and Rectal Surgeons of India
The upcoming portfolio of respiratory products aims to provide effective solutions for a range of respiratory conditions
ProBioGen was able to carry on its rapid growth trajectory by completing a significantly increased number of projects.
This expansion follows the groundbreaking of a large-scale commercial drug product facility in Stein (CH), in another milestone for Lonza’s Drug Product Services (DPS) offering
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
Brimonidine Tartrate Ophthalmic Solution is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure
Subscribe To Our Newsletter & Stay Updated
